Nimesulide is a chemical compound, sulphonamide.
It occurs in the form of a yellow powder. Stable. Incompatible with strong oxidising agents.

What it is used for and where
Medicine
Take only under medical supervision
Non-steroidal anti-inflammatory drug (NSAID) with analgesic and antipyretic properties, launched in 1985 in Italy and marketed in more than 50 countries worldwide with relatively low risk of gastrointestinal side effects. Not available in the United States.
Brief history
Nimesulide was reported to be hepatotoxic in 1997 and its use was restricted or banned in 2002 first in Finland and then in Spain due to the high frequency of associated hepatotoxicity (1). However, several studies have downgraded the problem and the European Medicines Agency (2), after an extensive study, recognised its efficacy in
- intense pain
- dysmenorrhoea
- pain from osteoarthritis
- pain from traumatic sprains and tendinitis
taking into account the risk/benefit ratio, only recommended a maximum daily dose for the 100mg dose. Stricter restrictions apply to the 200mg dose.
An important study from 2010 clarifies the risk/benefit ratio comprehensively: "Results suggest that implementation of regulatory actions regarding nimesulide may have prevented 79 admissions for liver damage, but increased admissions for UGIB by 859 cases."
Nimesulide as a preferential inhibitor of cyclooxygenase-2 could play a potential therapeutic role in the management of patients with cerebral ischaemia (4) and, together with silver complexes, a potential and safe agent for the topical treatment of skin cancer in humans (5).
Antidiabetic activity of Nimesulide has also been demonstrated (6).
However, recently, a study by Brazilian, Spanish and Argentinean researchers reiterated, this time negatively, the risk/benefit ratio of Nimesulide (7). Frankly, from the consumer's point of view, it is difficult to make a choice since the same doctors give opposite opinions.
Like all drugs it can cause side effects. Always ask the physician.
For more information: Nimesulide studies
| Appearance | Yellow powder |
| Boiling Point | 442.0±55.0 °C at 760 mmHg |
| Melting Point | 140-146°C |
| Flash Point | 221.1±31.5°C |
| Density | 1.5±0.1 g/cm3 |
| Vapour Pressure | 0.0±1.1 mmHg at 25°C |
| Index of Refraction | 1.638 |
| PSA | 109.60000 |
| LogP | 3.79 |
| Safety | ![]() |
![]() | ![]() |
![]() | ![]() |
- Molecular Formula C13H12N2O5S
- Linear Formula CH3(CH2)3CH(C2H5)CH2O2CCH2CH(SO3Na)CO2CH2CH(C2H5)(CH2)3CH3
- Molecular Weight 308.31
- Exact Mass 308.046692
- CAS 51803-78-2
- UNII V4TKW1454M
- EC Number 257-431-4
- DSSTox Substance ID DTXSID3037250
- IUPAC N-(4-nitro-2-phenoxyphenyl)methanesulfonamide
- InChI=1S/C13H12N2O5S/c1-21(18,19)14-12-8-7-10(15(16)17)9-13(12)20-11-5-3-2-4-6-11/h2-9,14H,1H3
- InChl Key HYWYRSMBCFDLJT-UHFFFAOYSA-N
- SMILES CS(=O)(=O)NC1=C(C=C(C=C1)[N+](=O)[O-])OC2=CC=CC=C2
- MDL number MFCD00012455
- PubChem Substance ID 24859403
- ChEBI 44445
- RTECS PB0970000
- NCI C29842
Synonyms
- Aulin
- Mesulid
- Flogovital
- Nisulid
- Sulidene
- Methanesulfonamide, N-(4-nitro-2-phenoxyphenyl)-
- Nimed
- Aldoron
- Nise Gel
- Nimedex
- Prestwick_618
- Orthobid




